<DOC>
	<DOCNO>NCT01285375</DOCNO>
	<brief_summary>The safety preliminary efficacy addition aqueous curcumin-cyclodextrin complex ( CDC ) solution graft perfusion solution study . CDC prove safe highly effective prevent primary graft non-function , delay graft function chronic dysfunction pre-clinical kidney transplantation animal model . The hypothesis addition CDC graft perfusion solution decrease incidence delay graft function human kidney transplantation subject .</brief_summary>
	<brief_title>Safety Preliminary Efficacy Treatment Kidney Allografts With Curcumin-containing Preservation Solution</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Patients ESRD assign kidney transplantation , write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>